High-frequency loss-of-function mutations have been detected in tumor suppressors, including TP53, Rb1, and APC. However, high-frequency (e.g., >10%) gain-of-function mutations in oncogenes have not been identified thus far. This evidence concerns the gene TP53 and neoplasm.